0000000001021127
AUTHOR
A. Negrotti
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial
Background: Safinamide modulates both dopaminergic and glutamatergic systems with positive effects on motor and non-motor symptoms of Parkinson's disease (PD). The drug utilization study SYNAPSES was designed to investigate the use of safinamide in routine clinical practice, as recommended by the European Medicines Agency. Objective: To describe the occurrence of adverse events in PD patients treated with safinamide in real-life conditions. Methods: The SYNAPSES trial is an observational, European, multicenter, retrospective-prospective cohort study. Patients were followed up to 12 months with analyses performed in the overall population and in patients aged >75 years, with relevant comorbi…
Planning and executing sequential motor acts in Parkinson Disease
Many experimental evidences highlighted that Parkinson Disease (PD) patients are particularly impaired in performing a sequence of movements. In the present experiment we focused to study how PD patients plan and execute an action constituted by the sequence of reaching-grasping an object (first motor act) and placing it on a second target (second motor act). We wished to determine whether properties of the target of the second motor act influenced the kinematics of first motor act. The results showed that PD patients modified, as the controls, the initial ballistic phase of reaching according to variation of second target position (object extrinsic properties). In particular, peak accelera…